A detailed history of Steward Financial Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Steward Financial Group LLC holds 55 shares of EXAS stock, worth $2,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Holding current value
$2,724
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$65.94 - $99.04 $3,626 - $5,447
55 New
55 $3,000
Q1 2023

May 05, 2023

BUY
$47.19 - $70.77 $1,462 - $2,193
31 Added 172.22%
49 $3,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $546 - $956
18 New
18 $0
Q2 2022

Jul 22, 2022

BUY
$35.61 - $76.23 $747 - $1,600
21 New
21 $0

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.